China plans to consolidate its three merger and antitrust agencies into a single body. What does this mean for dealmakers?
The ongoing evolution of China’s state ministries may have significant implications for dealmakers.
As part of a bureaucratic overhaul, a new antitrust regulator, the State Administration for Market Supervision (SAMS), is being introduced, essentially consolidating the three competition authorities China has today: The Anti-Monopoly Bureau of the Ministry of Commerce (MOFCOM), the Price Supervision/Inspection and Anti-Monopoly Bureau of the National Development and Reform Commission (NDRC), and the Anti-Monopoly and Anti-Unfair Competition Bureau of the State Administration of Industry and Commerce (SAIC).
Each existing Chinese authority has its own remit and responsibilities. MOFCOM oversees all mergers in the country, NDRC reviews anti-monopoly pricing conduct, and SAIC is responsible for any other anti-competitive conduct not related to pricing.
In practice, this separation of duties among the competition authorities has sometimes proved confounding. For example, if a company were to engage in anti-competitive behavior that involves both price-fixing and withholding patents, it could come under two separate investigations from the NDRC and SAIC, and face double punishments, all for a single violation.
Featured News
European Commission Approves Nippon Steel’s $14.9 Billion Buyout of U.S. Steel
May 6, 2024 by
CPI
Banco Sabadell Rejects Rival BBVA Merger Proposal
May 6, 2024 by
CPI
Novo Nordisk Foundation’s Acquisition Faces Regulatory Hurdles
May 6, 2024 by
CPI
Microsoft’s MAI-1 to Compete with Google and OpenAI in AI Language Models
May 6, 2024 by
CPI
Qantas Settles ‘Ghost Flights’ Case With Australian Watchdog for $120 Million
May 6, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI